PALOP Coalition in Action: Practical Haemophilia Training in Angola – NNHF
Novo Nordisk Haemophilia and Haemoglobinopathies Foundation shared a post on LinkedIn:
”PALOP coalition in action: practical haemophilia training in Angola
The NNHF-supported PALOP coalition, connecting African Countries with Portuguese as Official Language or Portuguese-speaking African countries, brings together Angola, Mozambique and Cape Verde to strengthen haemophilia diagnosis, expand care and build regional collaboration.
This August, the collaboration continued in Luanda with the 2nd International Workshop on Haemophilia, hosted at the Dra. Victória do Espírito Santo Pediatric Hematology Institute.
The one-week training complemented the World Federation of Hemophilia twinning programme between Angola and Brazil’s State University of Campinas, bringing together more than 20 healthcare professionals from Angola, Mozambique, Cape Verde and Brazil for specialised training and multidisciplinary exchange. Participants included haematologists, paediatricians, laboratory technicians, nurses, dentists and physiotherapists.
As NNHF has expanded its support to include haemoglobinopathies, the training also strengthened healthcare professionals’ capacity in sickle cell disease management. Thank you to Dr Bruno Benites, haemotherapist from State University of Campinas, for providing specialised training on red blood cell exchange, erythrocytapheresis.
This coalition is a strong example of how existing partnerships, shared language and regional learning can help strengthen care across borders.
Explore the H1 2026 Half-Year Programme Report to discover how the PALOP project is progressing across Angola, Cape Verde and Mozambique:”

Stay updated with Hemostasis Today.
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day
-
Oct 17, 2026, 23:18Maha Othman: Establishing ISTH-BAT Reference Ranges for Children and Adolescents
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026